These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24142306)

  • 1. Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.
    Roussotte FF; Daianu M; Jahanshad N; Leonardo CD; Thompson PM
    Brain Imaging Behav; 2014 Jun; 8(2):217-233. PubMed ID: 24142306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.
    Hao X; Yao X; Yan J; Risacher SL; Saykin AJ; Zhang D; Shen L;
    Neuroinformatics; 2016 Oct; 14(4):439-52. PubMed ID: 27277494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms].
    Villain N; Chételat G; Desgranges B; Eustache F
    Biol Aujourdhui; 2010; 204(2):145-58. PubMed ID: 20950559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease.
    Chiesa PA; Cavedo E; Lista S; Thompson PM; Hampel H;
    Trends Neurosci; 2017 Aug; 40(8):469-480. PubMed ID: 28684173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history and APOE-4 genetic risk in Alzheimer's disease.
    Donix M; Small GW; Bookheimer SY
    Neuropsychol Rev; 2012 Sep; 22(3):298-309. PubMed ID: 22359096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
    Reinvang I; Espeseth T; Westlye LT
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.
    Braskie MN; Thompson PM
    Trends Cogn Sci; 2013 Oct; 17(10):510-6. PubMed ID: 24029445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
    Neale N; Padilla C; Fonseca LM; Holland T; Zaman S
    Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Alzheimer's disease risk genes in ischemic brain degeneration.
    Ułamek-Kozioł M; Pluta R; Januszewski S; Kocki J; Bogucka-Kocka A; Czuczwar SJ
    Pharmacol Rep; 2016 Dec; 68(6):1345-1349. PubMed ID: 27710863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to brain connectivity reveals early structural changes in Alzheimer's disease.
    La Rocca M; Amoroso N; Monaco A; Bellotti R; Tangaro S
    Physiol Meas; 2018 Jul; 39(7):074005. PubMed ID: 29943735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer's disease.
    Forouzannezhad P; Abbaspour A; Fang C; Cabrerizo M; Loewenstein D; Duara R; Adjouadi M
    J Neurosci Methods; 2019 Apr; 317():121-140. PubMed ID: 30593787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
    Abdelaziz M; Wang T; Elazab A
    J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
    Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
    J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance.
    Hnilicova P; Kantorova E; Sutovsky S; Grofik M; Zelenak K; Kurca E; Zilka N; Parvanovova P; Kolisek M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging for drug addiction and related behaviors.
    Parvaz MA; Alia-Klein N; Woicik PA; Volkow ND; Goldstein RZ
    Rev Neurosci; 2011; 22(6):609-24. PubMed ID: 22117165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Sheng J; Wang L; Cheng H; Zhang Q; Zhou R; Shi Y
    Neurosci Lett; 2021 Sep; 762():136147. PubMed ID: 34332030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.
    Braskie MN; Thompson PM
    Biol Psychiatry; 2014 Apr; 75(7):527-33. PubMed ID: 24367935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci.
    Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A
    Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.
    Bai F; Yuan Y; Shi Y; Zhang Z
    Oncotarget; 2016 Mar; 7(13):15315-28. PubMed ID: 26985771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.